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Abstract 
The pathophysiological mechanisms which lead to sudden infant death syndrome (SIDS) are not completely under‑
stood. Cardiac channelopathies are a well‑established causative factor with long QT syndrome (LQTS) being the most 
frequent one, accounting for approximately 12% of SIDS cases. The genetic substrate of the above arrhythmogenic 
syndrome has been thoroughly described but only specific gene mutations or polymorphisms have been identified 
as SIDS causative. The review will focus on the prevalence of LQTS‑induced SIDS or near‑SIDS cases and the mutations 
held responsible. A literature search was performed in PubMed and Scopus electronic databases. Search terms used 
were: long QT syndrome, channelopathies, QT prolongation, cardiac ion channels. The above‑mentioned search terms 
were always combined with the term: sudden infant death syndrome. Study types considered eligible were: case–
control, family pedigree analysis, case reports. The prevalence of LQTS‑induced SIDS according to six broad genetic 
studies ranges from 3.9 to 20.6%, with an average of 12%. Since LQTS can be effectively managed, LQTS‑related SIDS 
cases could be prevented, provided that a screening method is efficient enough to detect all the affected infants.
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Background
Cardiac ion channelopathies have been found to be 
implicated as a causative factor of sudden infant death 
syndrome (SIDS) by numerous studies. The first chan-
nelopathy hypothesized to be linked with SIDS was the 
long QT syndrome (LQTS) in a study conducted in 1976 
by Schwarz [1]. Since then, Brugada Syndrome (BrS) and 
catecholaminergic polymorphic ventricular tachycardia 
(CPVT) have been listed as possible causes, with short 
QT syndrome (SQTS) the most recent addition to the 
list. It is remarkable that long QT syndrome has recently 
been found to account for almost 12% of SIDS cases [2]. 
The purpose of this review is to summarize and present 
major studies (mostly case–control) which investigate 
the relationship between the two pathological entities 
up to date. The review will focus on the prevalence of 
LQTS-induced SIDS or near-SIDS cases and the muta-
tions held responsible. Since LQTS can be adequately 
managed, LQTS-related SIDS cases could be prevented, 
provided that a screening method is efficient enough to 
detect all the affected infants. The systematic classifica-
tion of the detected gene variations could serve as a basis 
for discriminating the most common of them and thus 
facilitate the development of targeted genetic screening 
in order to prevent the tragic event of sudden death in 
infancy.
Sudden infant death syndrome (SIDS)
Sudden infant death syndrome was first defined as a 
pathological entity in 1969 as “the sudden death of any 
infant or young child, which is unexpected by history, 
and in which a thorough post-mortem examination fails 
to demonstrate an adequate cause of death” [3]. However, 
the definition above was deemed too non-specific since it 
lacked an age limitation and was based solely on the post-
mortem body dissection excluding the autopsy of the sur-
rounding environment. This is the reason why in 1989 the 
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National Institute of Child Health and Human Develop-
ment (NICHD) set out to redefine SIDS [4]. The revised 
definition limited the age of the infant to under 1 year old 
(<1 year) and stated that the diagnosis of SIDS should only 
be made if a complete autopsy of the death scene and a 
clinical history (in addition to an unremarkable post-mor-
tem examination) fail to identify any other specific cause 
of death [5]. In 2003, after years of controversies, Bruce 
Beckwith, the visionary of a solid definition, pointed out 
the need of re-evaluating the definition and categorizing 
SIDS cases so an expert panel was formed in 2004 in San 
Diego to address the matter [3, 6]. The San Diego defini-
tion as named, is therefore the most recent and system-
atic one and is widely accepted for the classification of 
SIDS cases [6]. It divides SIDS cases into three categories, 
according to specific clinical findings and autopsy results 
and modifies the 1989 definition by adding the condition 
that the death must occur during sleep.
Several factors have been accused of triggering SIDS 
such as maternal age, maternal race, alcohol and tobacco 
use during pregnancy, low birth weight, male gender, 
bed sharing and prone sleeping position [7–10]. Despite 
a notable decline of about 50% in SIDS related deaths, 
SIDS continues to be the leading cause of post-neonatal 
death in the USA even after the launch of the “Back to 
Sleep” campaign [11].
An accurate pathophysiological model able to explain 
SIDS is not yet established. Various “triple risk mod-
els” have been proposed, correlating environmental and 
intrinsic risk factors which subsequently lead to a vulner-
able infant [12]. Injuries and neurochemical abnormali-
ties of the brainstem have been linked to SIDS. Brainstem 
gliosis possibly causing hypoxemic events in infant vic-
tims was found to be related with maternal smoking [13]. 
Serotonin transporter gene polymorphisms undermin-
ing the infantile brainstem’s response to hypoxia or 
hypercapnia are also characterized as SIDS risk factors 
[14, 15]. Bacterial and viral infections as well as immu-
nologic polymorphisms (interleukin-10 over-secretion, 
interleukin-1β and Vascular Endothelial Growth Factor 
overexpression) are considered triggering factors [16]. 
Infants with alterations of the intestinal flora, more spe-
cifically infant hosts of enterotoxin producing Staphy-
lococcus aureus, are found to be more susceptible to 
SIDS than non-toxigenic S. aureus hosts [17]. Finally, 
arrhythmogenic cardiac ion channelopathies (LQTS, 
SQTS, BrS and CPVT) are established SIDS causative 
factors with LQTS being the most frequent one.
Methods
A literature search was performed in PubMed (https://
www.ncbi.nlm.nih.gov/pubmed) and Scopus (https://
www.scopus.com/home.uri) electronic databases. The 
latest data retrieval date was December 2015. Search 
terms used were: long QT syndrome, channelopathies, 
QT prolongation, cardiac ion channels. The above-
mentioned search terms were always combined with the 
term: sudden infant death syndrome. Abbreviations of 
the above syndromes were also used in the search. Stud-
ies had to satisfy the new definition of SIDS as well as the 
classification criteria, all of which were introduced in San 
Diego in 2004. Articles studying a sudden unexplained 
death population which contained a sub-population of 
SIDS cases were also included in the review. Study types 
considered eligible were: case–control, family pedigree 
analysis, case reports.
Results
We identified 13 case–control studies investigating the 
prevalence of LQTS-induced SIDS [2, 18–29]. Six of 
them were broad genetic studies of an unselected SIDS 
population and screened cases for a majority of the 
LQTS-causing genes known at the time of the study 
[18–23], whereas the rest concentrated on one or two 
specific genes [24–29]. The prevalence of LQTS-induced 
SIDS according to the six broad studies ranged from 3.9 
to 20.6%, with an average of 12% [18–23]. A separate and 
more detailed discussion of the results, regarding the 
implication of LQTS in SIDS, is provided right below.
The role of long QT syndrome in sudden infant 
death syndrome
From a historical perspective, in February 1976, Schwartz 
published the completely novel hypothesis suggesting 
that LQTS could contribute to a number of SIDS cases 
[1]. In September of the same year, Maron et al. [30] pro-
posed the connection between LQTS and SIDS. They 
studied 42 sets of parents who had at least one child with 
SIDS. In 1998, Schwartz et  al. [31] confirmed their ini-
tial hypothesis through the results of their study which 
included 34,442 newborns and lasted for 18 years. They 
concluded that an evident prolongation of the QT inter-
val on days 3 and 4 of life was associated with a higher 
risk of SIDS occurrence. Two years later, the first molec-
ular evidence of the appearance of long QT syndrome 
in SIDS was published [32]. Since then, mutations in 7 
genes, KCNQ1, KCNH2/HERG, SCN5A, KCNE2, CAV3, 
SCN4B, SNTA1 causing the LQTS, have been associ-
ated with SIDS cases [2, 18–29]. A brief schematic of the 
mechanism through which cardiac ion channel muta-
tions lead to the prolongation of the QT interval is pro-
vided in Fig. 1.
In our review, we divided eligible studies in two sepa-
rate subsets. The first one consists of broad genetic 
studies of an unselected SIDS population. Their results 
are summarized in Table  1. These studies performed 
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mutational analysis of all the LQTS-related genes known 
at the time they were conducted. The second sub-
set consists of studies investigating the prevalence of 
SIDS-causative mutations of one specific gene or two, 
and is presented in Table 2.
It is obvious that the most accurate way to estimate the 
prevalence of LQTS-induced SIDS is to summarize the 
results of major genetic studies. Those, include a suffi-
cient enough population to reach safe conclusions, have 
an extended data collection period and most impor-
tantly, as already mentioned, performed mutational 
analysis on the majority of LQTS-related genes. The 
functional effect of the detected mutations was con-
firmed by electrophysiological methods after they were 
expressed in cell cultures. The study of Arnestad et al. [2] 
is considered as a significant milestone in the search for a 
genetic connection between SIDS and channelopathies. 
It is one of the largest studies conducted; it included 201 
Norwegian SIDS cases which were strictly identified as 
such, according to the Nordic criteria of SIDS [33]. Gene 
panels were used to detect mutations in cardiac sodium 
and potassium channel genes. It is remarkable that this 
study was the first to report that approximately 9.5% of 












Fig. 1 Functional effect of cardiac ion channel mutations on the 
repolarization/depolarization capacity of the myocardium
Table 1 Long QT syndrome as a causative factor of SIDS and implicated mutations—Broad genetic studies
* Sequence variation is previously unreported and is of the type which may or may not be causative of the disorder
Study/year Study type Total number 
of cases




Wang et al./2014 [18] Case–control 141 19 (13.4%) SCN5A p.L618F, p.P1011L*, p.A1100V, p.T1131I, 
p.T1304M, p.M1487L, p.Q1832E, p.R1944X*, 
p.D501G, p.A662S*, p.A997D*, p.A1106S*, 
p.S1285G*, p.A149V*, p.E1890K*
KCNQ1 p.Y51C*, p.P99R*, p.N593K*
KCNH2 p.D982N*
KCNE2 p.M54T
Glengarry et al./2014 [19] Case–control 102 4 (3.9%) SCN5A p.I759F, p.F1522Y*
KCNH2 p.R1047L
KCNQ1 p.E146K
Horigome et al./2010 [20] Case–control 58 12 near SIDS (20.6%) SCN5A p.V176M, p.N406K, p.R1623Q, p.L1772V
KCNH2 p.A561V, p.G628S, p.T613M, p.G572S, p.A614V, 
p.N633S
KCNQ1 p.G643S, p.G269S




Otagiri et al./2008 [22] Case–control 42 4 (9.5%) SCN5A p.G1084S, p.F1705S, p.F532C
KCNH2 p.T895M
KCNQ1 p.K598R
Arnestad et al./2007 [2] Case–control 201 19 (9.4%) SCN5A p.S216L, p.A586_L587del, p.R680H, p.T1304M, 
p.F1486L, p.V1951L, p.F2004L, p.P2006A
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SIDS cases concealed a phenotype of LQTS. More spe-
cifically, the majority of the mutations were detected 
in the SCN5A gene. These mutations caused either an 
increased persistent sodium current or accelerated inac-
tivation of the sodium channels. Furthermore, it has 
been noticed that SCN5A mutations serve as a trigger 
for arrhythmias during sleep [34]. This trigger, in com-
bination with several predisposing factors (prone sleep-
ing position, elevated sympathetic activity during REM 
sleep, respiratory infections), induced an enhanced 
cardiac electrical instability state and might subse-
quently lead to SIDS [35]. Mutations in the KCNQ1 
gene (p.G460S) and KCNH2 gene (p.R273Q, p.R954C/p.
K897T) led to a loss of function phenotype. Interest-
ingly, certain mutations were capable of causing a fatal 
QT prolongation without the influence of any other trig-
gering factor, as proven when they were expressed in 
laboratory animals.
Focusing on the most recent studies, in 2014, Wang 
et al. [18] separated another large and ethnically diverse 
cohort of 274 cases of sudden unexplained death in two 
groups, infants (141 cases) and non-infants (133 cases). 
Mutations responsible for LQTS were detected in 13.4% 
of infant cases, most frequently in the SCN5A gene. As in 
other broad genetic studies SIDS-related mutations were 
detected in genes which encode the potassium channel 
complex (KCNQ1, KCNH2, KCNE2), too.
Several studies focused on one single gene, rather than 
using gene panels. Cronk et al. [26] considered the pos-
sibility of CAV3 gene mutations resulting in SIDS. Their 
hypothesis was based on the observation that CAV3 
mutations strongly affect the SCN5A sodium channel by 
inducing a persistent late sodium current thus serving as 
a substrate for LQTS [36]. They concluded that 2.2% of 
cases were due to CAV3 mutations. Tan et al. [24] ana-
lyzed another large cohort of 292 SIDS cases, submitted 
to the Mayo Clinic Windland Smith Rice Sudden Death 
Genomics Laboratory. They noticed that 1% of cases 
were due to variants of the SNTA1 gene, which increased 
peak and late sodium current and led to LQTS type 12. 
Cheng et  al. [25] performed mutational analysis of the 
SCN4B gene, using the above-mentioned cohort. The 
variant p.S206L increased late sodium current and pos-
sibly led to LQTS type 10.
Conclusions and discussion
The sudden death of an infant is a devastating event, 
which raises two major concerns for the family. First, 
the grief for the unexpected loss of an apparently healthy 
infant and second, the uncertainty for future childbirths. 
Subsequently, SIDS cases should be managed by a mul-
tidisciplinary team of scientists consisting of a variety 
of specialties such as pediatricians, pediatric cardiolo-
gists as well as adult cardiologists, pathologists, coroners, 
geneticists and psychiatrists. As we can infer from the 
tables provided, several cardiac ion channel mutations 
are possibly SIDS causative. However, no solid criteria 
based on genetic testing have been established in order 
to point out high risk infants. This is due to the fact that 
each affected infant has its unique mutational profile 
regarding the implicated genes. The majority of the stud-
ies conducted are based solely on post-mortem genetic 
analysis and due to ethical regulations the identity of the 
victims cannot be revealed. As a result, no family pedi-
gree analysis can be performed nor genetic counseling 
provided. Moreover, no ideal screening method has been 
proposed, yet. In 2011, the Heart Rhythm Society (HRS) 
and the European Heart Rhythm Association (EHRA), 
published recommendations concerning the genetic test-
ing of individuals for channelopathies and cardiomyo-
pathies. Family genetic screening is recommended for 
all first degree relatives of a member affected by LQTS, 
BrS and CPVT but no universal neonatal screening is dis-
cussed or mentioned [37].
Table 2 Long QT syndrome as a causative factor of SIDS and implicated mutations—Genetic studies focusing on one sin-
gle or two genes
* Sequence variation is previously unreported and is of the type which may or may not be causative of the disorder
Study/year Study type Total number 
of cases
Number of SIDS cases 
with causative mutation
Genes Mutations
Kato et al./2014 [23] Case–control 7 4 SCN5A p.N1774D, p.F1486del, p.N406K
KCNH2 p.G628D
Tan et al./2010 [24] Case–control 292 1 (0.3%) SCN4B p.S206L*
Cheng et al./2009 [25] Case–control 292 3 (1%) SNTA1 p.S287R, p.T372M, p.G460S
Cronk et al./2007 [26] Case–control 134 3 (2.2%) CAV3 p.V14L, p.T78M, p.L79R
Plant et al./2006 [27] Case–control 133 7 (5.2%) SCN5A p.S1103Y, p.S524Y, p.R689H, 
p.E1107K
Lupoglazoff et al./2004 [28] Case–control 23 3 (13%) KCNH2 p.G604S
Ackerman et al./2001 [29] Case–control 93 2 (2.1%) SCN5A p.A997S, p.R1826H
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The usefulness of electrocardiographic (ECG) screen-
ing as a universal method for identifying the affected 
infants was pointed out by Schwartz et  al. in 2002 [38]. 
To their view, a neonatal ECG is commonly unknown 
territory to the eyes of an adult cardiologist. Therefore, 
the aim of their report was to provide simple guidelines 
for its interpretation. The efficacy of ECG screening is 
addressed by two independent studies, carried out in 
2000 and 2006 [39, 40]. Both focused on the LQTS, as it 
is the most common channelopathy among BrS, CPVT 
and SQTS and mainly analyzed the cost effectiveness of 
ECG screening. The first study of Zupancic et al. in 2000 
[39], appears to have two possible weaknesses: the under-
estimation of the prevalence of LQTS (1/10,000) and the 
time point of ECG screening, which was performed early 
enough (day 3 of life) to confuse the normal prolonga-
tion of the QT interval during the neonatal period with 
the pathological one. Quaglini et  al. in 2006 had more 
studies investigating the prevalence of LQTS at their dis-
posal and they considered its prevalence to be 1/2500, 
much closer to reality [40]. Moreover, the ECG screen-
ing was performed during the 3rd or 4th week of life, a 
period more sensitive to identify the affected infants. 
Both studies suggest that universal neonatal ECG screen-
ing, despite the false negative or false positive results 
(which are unavoidable since the QT interval is not sta-
ble throughout the neonatal period and some infants car-
rying causative mutations may not have ECG findings), 
remains a cost-effective method.
As far as genetic screening is concerned, efficient map-
ping of the responsible genes could lead to the devel-
opment of targeted, rapid genetic tests for the most 
common ones. In 2009, Redpath et  al. [41] published a 
case report of a 22 year old man with a borderline short-
ening of the QT interval and proposed the use of rapid 
direct DNA sequencing in order to facilitate the diag-
nosis of the SQTS. The test yielded positive results in 
less than 72 h by identifying a mutation in the KCNH2 
gene. Rapid genetic tests for Long QT Syndrome would 
be more challenging to develop since 16 genes have been 
found to cause LQTS, out of which more than 7 have 
been commonly linked to SIDS cases [42]. However, it 
would be naive to consider that the less common ones 
are not likely to contribute to SIDS. The most glaring 
example is represented by mutations on calmodulin, 
which can clearly lead to deaths that would be inter-
preted as SIDS [43]. Next generation whole genome 
sequencing (WGS) seems to achieve promising results. 
Rapid molecular diagnosis of LQTS at 10  days of life 
by WGS has been described by Priest et  al. [44]. The 
test provided accurate readings in 8  days. In the case 
of deceased infants, when family genetic counseling 
and screening is required, molecular autopsy could be 
efficiently performed by WGS of DNA extracted from 
stored dried blood spot cards (also known as Guthrie 
cards, tiny blood samples obtained by pricking the 
infant’s heel). Breakthrough techniques allow the ampli-
fication of DNA received from such samples and are able 
of yielding reliable and rapid results [45]. However, par-
ents should be aware that the detection of a mutation by 
molecular autopsy does not guarantee the appearance 
of an arrhythmogenic phenotype in the family nor justi-
fies the exact cause of death for the infant. Last but not 
least, future research should aim to identify the patho-
genetic mechanisms at the core of SIDS. This will enrich 
our knowledge and understanding of such a tragic event 
and help us develop more efficient preventive measures 
as well as improved counseling.
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